Next Act Fund

Astarte Medical Partners, Inc. is a clinical intelligence company focused on enhancing health outcomes for children with medical complexities, particularly in neonatal intensive care units (NICUs). Incorporated in 2016 and based in Yardley, Pennsylvania, the company develops software that delivers a comprehensive view of clinical data in real time, specifically aimed at assessing the gut health of preterm infants. This platform allows clinical care teams to standardize and optimize feeding practices and protocol-driven care, thereby facilitating informed decision-making. Astarte Medical's suite of digital tools and predictive analytics supports nutrition and feeding practices, enabling healthcare providers to monitor growth and track clinical outcomes effectively. By improving care practices in acute settings, the company strives to make a significant impact on the long-term health of vulnerable pediatric populations.

Astarte Medical Partners, Inc. is a clinical intelligence company focused on enhancing health outcomes for children with medical complexities, particularly in neonatal intensive care units (NICUs). Incorporated in 2016 and based in Yardley, Pennsylvania, the company develops software that delivers a comprehensive view of clinical data in real time, specifically aimed at assessing the gut health of preterm infants. This platform allows clinical care teams to standardize and optimize feeding practices and protocol-driven care, thereby facilitating informed decision-making. Astarte Medical's suite of digital tools and predictive analytics supports nutrition and feeding practices, enabling healthcare providers to monitor growth and track clinical outcomes effectively. By improving care practices in acute settings, the company strives to make a significant impact on the long-term health of vulnerable pediatric populations.

Astarte Medical Partners, Inc. is a clinical intelligence company focused on enhancing health outcomes for children with medical complexities, particularly in neonatal intensive care units (NICUs). Incorporated in 2016 and based in Yardley, Pennsylvania, the company develops software that delivers a comprehensive view of clinical data in real time, specifically aimed at assessing the gut health of preterm infants. This platform allows clinical care teams to standardize and optimize feeding practices and protocol-driven care, thereby facilitating informed decision-making. Astarte Medical's suite of digital tools and predictive analytics supports nutrition and feeding practices, enabling healthcare providers to monitor growth and track clinical outcomes effectively. By improving care practices in acute settings, the company strives to make a significant impact on the long-term health of vulnerable pediatric populations.